CTRI/2020/11/029211招募中未知
Genetic factors of Plasmodium falciparum and Plasmodium vivax associated with Infection, Transmission and Drug response
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Inclusion criteria (Controls): Consenting individuals of male and female genders above 18 years. Healthy individuals with no history of malaria and other medical complications (G6PD deficiency, diabetic, Haemoglobinopathies, etc).
- •Inclusion criteria (Case): Consenting individuals of all genders above 18 years. P. falciparum or P. vivax malaria-infected individuals.
排除标准
- •Exclusion criteria (Controls): Participants of all genders below 18 years. Healthy individuals with a history of malaria. Participants with other medical complications (G6PD deficiency, diabetic, Haemoglobinopathies, etc)
- •Exclusion criteria (Case): Participants of all genders below 18 years. Study participants with mixed Plasmodium infection and other medical conditions (G6PD deficiency, diabetic, Haemoglobinopathies, etc).
研究者
相似试验
招募中
不适用
Comparison of three Plasmodium falciparum isolates in an experimental human malaria infectioplasmodium falciparum10037072MalariaNL-OMON34733niversitair Medisch Centrum Sint Radboud15
已完成
不适用
Comparison of three Plasmodium falciparum isolates in a controlled human malaria infectiomalariaNL-OMON37044niversitair Medisch Centrum Sint Radboud15
已完成
不适用
Efficacy of artemether-lumefantrine treatment in uncomplicated malaria (Plasmodium falciparum) patients and in-vitro experiment on susceptibility of malaria (P. falciparum) strains to new chemical substancesISRCTN08391109Medicines for Malaria Venture (MMV) (Switzerland)110
尚未招募
不适用
nderstanding Plasmodium falciparum malaria in the Amazon: implications for the national malaria control programncomplicated malariaPlasmodium falciparumBrazilPlasmodium falciparum histidine-rich protein-2 genetherapeutic efficacy trialArtemisinin-based combination therapyParasitological clearance rateRBR-634ymd5Instituto Nacional de Infectologia Evandro Chagas
已完成
不适用
Safety, Tolerability and Plasmodium falciparum transmission-reducing activity of R0.6C vaccine adjuvanted with Alhydrogel alone or combined with Matrix-M in healthy malaria-naïve adults in the NetherlandsmalariaNL-OMON51178Radboud Universitair Medisch Centrum32